Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Molnupiravir (MK-4482) (EIDD-2801) is a prodrug of the ribonucleoside analog EIDD-1931 which is orally bioavailable. Molnupiravir can be used in COVID-19, seasonal and pandemic influenza research that has broad spectrum antiviral activity against multiple coronaviruses and influenza virus, for example, SARS-CoV-2, MERS-CoV, SARS-CoV [1][2].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | In stock | $ 34.00 | |
10 mg | In stock | $ 55.00 | |
25 mg | In stock | $ 72.00 | |
50 mg | In stock | $ 122.00 | |
100 mg | In stock | $ 197.00 | |
200 mg | In stock | $ 372.00 | |
500 mg | In stock | $ 788.00 | |
1 g | In stock | $ 1,080.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 61.00 |
Description | Molnupiravir (MK-4482) (EIDD-2801) is a prodrug of the ribonucleoside analog EIDD-1931 which is orally bioavailable. Molnupiravir can be used in COVID-19, seasonal and pandemic influenza research that has broad spectrum antiviral activity against multiple coronaviruses and influenza virus, for example, SARS-CoV-2, MERS-CoV, SARS-CoV [1][2]. |
In vitro | Molnupiravir (50-500 mg/kg; p.o.; every 12 hours for 3 days) is robustly antiviral and able to prevent SARS-CoV replication and disease[1]. Molnupiravir (7 mg/kg; p.o.; twice daily for 3.5 days) significantly reduces shed virus load and duration of fever[2]. |
Synonyms | EIDD-2801, Lagevrio, MK-4482 |
Molecular Weight | 329.31 |
Formula | C13H19N3O7 |
CAS No. | 2492423-29-5 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 45 mg/mL (136.6 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Molnupiravir 2492423-29-5 Microbiology/Virology Influenza Virus SARS-CoV EIDD-2801 EIDD 2801 MK4482 EIDD2801 MK 4482 Lagevrio MK-4482 inhibitor inhibit